In March 2023, the CNIC launched its Isotopes for Hope campaign, focused on the goal of expanding Canada’s global leadership in the development, supply, and use of medical isotopes and raising awareness for the pivotal role that isotopes play in modern medicine.

As part of Phase 1 of the Isotopes for Hope campaign, the CNIC released a new report entitled “Isotopes for Hope: Canadian Leadership Needed Now More Than Ever.” The report offers updated market figures, emerging trends for isotopes, and opportunities for Canada in the global market.

The global market for nuclear medicine is anticipated to reach up to US$42 billion by 2033. Given the significant opportunities for Canada to act as a global leader in the fight against cancer, the Isotopes for Hope campaign is built upon an ambitious vision of doubling Canada’s production of medical isotopes by 2030 to meet rising need.

Furthering the CNIC’s advocacy efforts through the Isotopes for Hope campaign, the CNIC released “Isotopes for Hope: Update on Recommendations” in October 2023, which serves as an update to the CNIC’s advocacy efforts through the campaign. The report summarizes the progress made on each recommendation, identifies ongoing industry challenges, and identifies advocacy focus areas for 2024, all to maintain momentum and continue working toward the goal of doubling production by 2030.

In November 2025, the CNIC marked the launch of the next phase of its Isotopes for Hope campaign with the release of a new report, “Isotopes for Hope: Canada’s 2030 Promise”.

This new report highlights the life-changing impact of medical isotopes and the significant economic opportunity they present for Canada, and also provides an update on the progress towards our goal of doubling domestic isotope production by 2030.

In 2024, the CNIC launched the Isotopes for Hope Podcast, hosted by our Chair, James Scongack. This multi-part series highlights Canadian leaders in the country’s isotope and cancer care sector who are contributing to Canada’s leadership role in fighting cancer. We aim to feature unique stories and perspectives about the importance of isotopes from industry leaders across the country.